TY - JOUR
T1 - Effect of CRF on the release of anterior pituitary hormones in normal subjects and patients with Cushing's disease
AU - D'Agata, R.
AU - Cavagnini, F.
AU - Invitti, C.
AU - Mongioi, A.
AU - Fossati, R.
AU - Scapagnini, U.
AU - Müller, E. E.
PY - 1984
Y1 - 1984
N2 - Patterning of plasma ACTH, β-EP/β-LPH and cortisol in response to ovine CRF (1 μg/Kg b.w.t. injected i.v.), was studied in three normal subjects and in five patients with Cushing's disease, two of whom had undergone total bilateral adrenalectomy. CRF caused in all subjects a prompt and concurrent rise of plasma hormone levels. The hormonal response was of the same magnitude in normal controls and in the three untreated Cushing's patients, but was much greater in the two adrenalectomized subjects. No changes were noted, after CRF, in plasma levels of GH, PRL, TSH, LH and FSH. These findings indicate that CRF specifically promotes the pituitary release of ACTH and ACTH-related peptides both in normal subjects and patients with Cushing's disease. In view of the likely CRF hypersecretion of the adrenalectomized patients, their ACTH and β-EP/β-LPH hyperresponsiveness to exogenous CRF would denote that the peptide does not down regulate its own pituitary receptors.
AB - Patterning of plasma ACTH, β-EP/β-LPH and cortisol in response to ovine CRF (1 μg/Kg b.w.t. injected i.v.), was studied in three normal subjects and in five patients with Cushing's disease, two of whom had undergone total bilateral adrenalectomy. CRF caused in all subjects a prompt and concurrent rise of plasma hormone levels. The hormonal response was of the same magnitude in normal controls and in the three untreated Cushing's patients, but was much greater in the two adrenalectomized subjects. No changes were noted, after CRF, in plasma levels of GH, PRL, TSH, LH and FSH. These findings indicate that CRF specifically promotes the pituitary release of ACTH and ACTH-related peptides both in normal subjects and patients with Cushing's disease. In view of the likely CRF hypersecretion of the adrenalectomized patients, their ACTH and β-EP/β-LPH hyperresponsiveness to exogenous CRF would denote that the peptide does not down regulate its own pituitary receptors.
UR - http://www.scopus.com/inward/record.url?scp=0021321343&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021321343&partnerID=8YFLogxK
U2 - 10.1016/S0031-6989(84)80113-7
DO - 10.1016/S0031-6989(84)80113-7
M3 - Article
C2 - 6326164
AN - SCOPUS:0021321343
VL - 16
SP - 303
EP - 311
JO - Pharmacological Research
JF - Pharmacological Research
SN - 1043-6618
IS - 3
ER -